Cancer care for individuals with schizophrenia

Cancer

Volumn 120, Issue 3, 2014, Pages 323-334

  Irwin, Kelly E ^a,b   Henderson, David C ^b   Knight, Helen P ^a   Pirl, William F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cancer; health care disparities; outcomes; schizophrenia; treatment

Indexed keywords

TAMOXIFEN;

CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CASE STUDY; CLINICAL TRIAL (TOPIC); HEALTH BEHAVIOR; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HOMELESSNESS; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MALIGNANT NEOPLASTIC DISEASE; MENTAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; RESEARCH PRIORITY; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; STIGMA; STRATEGIC PLANNING; SUICIDE; TERMINAL CARE; VIOLENCE;

CANCER; HEALTH CARE DISPARITIES; OUTCOMES; SCHIZOPHRENIA; TREATMENT;

COOPERATIVE BEHAVIOR; EARLY DETECTION OF CANCER; HEALTHCARE DISPARITIES; HUMANS; NEOPLASMS; PATIENT CARE TEAM; SCHIZOPHRENIA;

EID: 84892913099     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28431     Document Type: Review

References (74)

1. Byers T, Barrera E, Fonthan ET, et al. A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015. Cancer. 2006; 107: 396-405.
2. Goss E, Lopez AM, Brown CL, Wollins DS, Brawley OW, Raghavan D,. American Society of Clinical Oncology Policy Statement: disparities in cancer care. J Clin Oncol. 2009; 27: 2881-2885.
3. Green MF, Kern RS, Heaton RK,. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004; 72: 41-51.
4. Colton C, Manderscheid R,. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in 8 states. Prev Chronic Dis. 2006; 3: A42.
5. Hennekens C, Hennekens A, Hollar D, Casey DE,. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005; 150: 1115-1121.
6. Brown S, Kim M, Mitchell C, Inskip H,. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry. 2010; 126: 116-121.
7. Capasso RW, Lineberry TW, Bostwick J, et al. Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005. Schizophr Res. 2008; 98: 287-294.
8. Crump C, Winkleby MA, Sundquist K, Sundquist J,. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013; 170: 324-333.
9. Saha S, Chant D, McGrath J,. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007; 64: 1123-1131.
10. Insell T,. Schizophrenia as a health disparity. National Institute of Mental Health Director's Blog [serial online]. Published March 29, 2013. nimh.nih.gov/about/director/2013/schizophrenia-as-a-health-disparity.shtml. Accessed July 23, 2013.
11. Parks J, Svendsen D, Singer P, Foti M,. Morbidity and Mortality in People With Serious Mental Illness. Alexandria, VA: National Association of State Mental Health Program Directors; 2006.
12. Kisely S, Sadek J, Mackenzie A, Lawrence D, Campbell LA,. Excess cancer mortality in psychiatric patients. Can J Psychiatry. 2008; 53: 753-761.
13. Lawrence D, Holman C, Jablensky A, Threlfall TJ, Fuller S,. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr Scand. 2000; 101: 382-388.
14. Kisely S, Crowe E, Lawrence D,. Cancer-related mortality in people with mental illness. JAMA Psychiatry. 2013; 70: 209-217.
15. Tran E, Rouillon F, Loze J-Y, Casadebaig F, Philippe A, Vitry F, Limosin F,. Cancer mortality in patients with schizophrenia. Cancer. 2009; 115: 3555-3562.
16. Catts V, Catts S, O'Toole B, Frost A,. Cancer incidence in patients with schizophrenia and their first-degree relatives-a meta-analysis. Acta Psychiatr Scand. 2008; 117: 323-336.
17. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C,. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Arch Gen Psychiatry. 2007; 64: 1368-1376.
18. Guan NC, Termorshuizen F, Laan W, et al. Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Soc Psychiatry Psychiatr Epidemiol. 2013; 48: 1289-1295.
19. Brown S, Barraclough B, Inskip H,. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000; 177: 212-217.
20. Hinshaw S, Stier A,. Stigma as related to mental disorders. Annu Rev Clin Psychol. 2008; 4: 367-393.
21. Corrigan PW, Larson JE, Rusch N,. Self-stigma and the "why try" effect: impact on life goals and evidence-based practices. World Psychiatry. 2009; 8: 75-81.
22. Thornicroft G,. Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry. 2011; 199: 441-442.
23. Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M,. Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet. 2009; 373: 408-415.
24. Pandya A, Bresee C, Duckworth K, Gay K, Fitzpatrick M,. Perceived impact of the disclosure of a schizophrenia diagnosis. Community Ment Health J. 2011; 47: 613-621.
25. Jones S, Howard LM, Thornicroft G,. Diagnostic overshadowing: worse physical health care for people with mental illness. Acta Psychiatr Scand. 2008; 118: 169-171.
26. Obuchi T, Okabayashi K, Imakiire T, Yoneda S, Iwasaki A,. The outcomes of surgery in lung cancer patients with schizophrenia [published online ahead of print April 18, 2013 ]. Surg Today.
27. Dickerson F, Stallings CR, Origoni AE, et al. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatr Serv. 2013; 64: 44-50.
28. Goff DC, Cather C, Evins AE, et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry. 2005; 66: 183-194.
29. Prochaska JJ,. Smoking and mental illness-breaking the link. N Engl J Med. 2011; 365: 196-198.
30. Tsoi DT, Porwal M, Webster AC,. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013; 2: CD007253.
31. Daumit G, Dickerson F, Wang N, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013; 368: 1594-1602.
32. Aggarwal A, Pandurangi A, Smith W,. Disparities in breast and cervical cancer screening in women with mental illness: a systematic literature review. Am J Prev Med. 2013; 44: 392-398.
33. Chochinov H, Martena PJ, Prior HJ, Fransoo R, Burland E,. Does a diagnosis of schizophrenia reduce rates of mammography screening? A Manitoba population-based study. Schizophr Res. 2009; 113: 95-100.
34. Xiong G, Bermudes R, Torres S, Hales R,. Use of cancer screening services among patients with serious mental illness in Sacramento County. Psychiatr Serv. 2008; 59: 929-932.
35. Tilbrook D, Polsky J, Lofters A,. Are women with psychosis receiving adequate cervical cancer screening? Can Fam Physician. 2010; 56: 358-363.
36. Kodl MM, Powell AA, Noorbaloochi S, Grill JP, Bangerter AK, Partin MR,. Mental health, frequency of healthcare visits, and colorectal cancer screening. Med Care. 2010; 48: 934-939.
37. Folsom DP, McCahill M, Bartels SJ, Lindamer LA, Ganiats TG, Jeste DV,. Medical comorbidity and receipt of medical care by older homeless people with schizophrenia or depression. Psychiatr Serv. 2002; 53: 1456-1460.
38. Salsberry PJ, Chipps E, Kennedy C,. Use of general medical services among Medicaid patients with severe and persistent mental illness. Psychiatr Serv. 2005; 56: 458-462.
39. Lord O, Malone D, Mitchell AJ,. Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. Gen Hosp Psychiatry. 2010; 32: 519-543.
40. Inagaki T, Yasukawa R, Okazaki S, et al. Factors disturbing treatment for cancer in patients with schizophrenia. Psychiatry Clin Neurosci. 2006; 60: 327-331.
41. Mateen F, Jatoi A, Lineberry TW, et al. Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology. 2008; 17: 721-725.
42. O'Rourke RW, Diggs BS, Spight DH, et al. Psychiatric illness delays diagnosis of esophageal cancer. Dis Esophagus. 2008; 21: 416-421.
43. Sharma A, Ngan S, Nandoskar A, et al. Schizophrenia does not adversely affect the treatment of women with breast cancer: a cohort study. Breast. 2010; 19: 410-412.
44. Hwang M, Farasatpour M, Williams CD, Margenthaler JA, Virgo KS, Johnson FE,. Adjuvant chemotherapy for breast cancer in patients with schizophrenia. Oncol Lett. 2012; 3: 845-850.
45. Baillargeon J, Kuo Y-F, Lin Y-L, Raji MA, Singh A, Goodwin JS,. Effect of mental disorders on diagnosis, treatment, and survival of older adults with colon cancer. J Am Geriatr Soc. 2011; 59: 1268-1273.
46. Farasatpour M, Janardhan R, Williams CD, Margenthaler JA, Virgo KS, Johnson FE,. Breast cancer in patients with schizophrenia [published online ahead of print July 12, 2013 ]. Am J Surg. doi: 10.1016/j.amjsurg. 2012.06.013.
47. Liao CC, Shen WW, Chang CC, Chang H, Chen TL,. Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann Surg. 2013; 257: 433-438.
48. Copeland L, Zeber J, Pugh M, Mortensen E, Restrepo M, Lawrence V,. Postoperative complications in the seriously mentally ill. Ann Surg. 2008; 248: 31-38.
49. Daumit GL, Pronovost PJ, Anthony CB, Guallar E, Steinwachs DM, Ford DE,. Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry. 2006; 63: 267-272.
50. Murthy VH, Krumholz HM, Gross CP,. Participation in cancer clinical trials. JAMA. 2004; 291: 2720-2726.
51. Unger JM, Hershman PL, Albain KS, et al. Patient income level and cancer clinical trial participation. J Clin Oncol. 2013; 31: 536-542.
52. Carpenter W, Gold J, Lahti A, et al. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry. 2000; 57: 533-538.
53. Halbreich U, Smail N, Tu X, Halbreich J,. Participation in clinical trials may improve care of acute schizophrenia inpatients in a general hospital. CNS Spectr. 2008; 13: 757-761.
54. Chochinov HM, Martens PJ, Prior HJ, Kredentser MS,. Comparative health care use patterns of people with schizophrenia near the end of life: a population-based study in Manitoba, Canada. Schizophr Res. 2012; 141: 241-246.
55. Martens PJ, Chochinov HM, Prior HJ,. Where and how people with schizophrenia die: a population-based, matched control study in Manitoba, Canada. J Clin Psychiatry. 2013; 74: e551-e557.
56. Ganzini L, Socherman R, Duckart J, Shores M,. End-of-life care for veterans with schizophrenia and cancer. Psychiatr Serv. 2010; 61: 725-728.
57. Candilis PJ, Foti ME, Holzer JC,. End-of-life care and mental illness: a model for community psychiatry and beyond. Community Ment Health J. 2004; 40: 3-16.
58. Foti ME, Bartels SJ, Merriman MP, Fletcher KE, Van Citters AD,. Medical advance care planning for persons with serious mental illness. Psychiatr Serv. 2005; 56: 576-584.
59. Howard LM, Barley EA, Davies E, et al. Cancer diagnosis in people with severe mental illness: practical and ethical issues. Lancet Oncol. 2010; 11: 797-804.
60. Palmer B, Pankratz S, Bostwick J,. The lifetime risk of suicide in schizophrenia. Arch Gen Psychiatry. 2005; 62: 247-252.
61. Misono S, Weiss N, Fann J, Redman M, and, Yueh B,. Incidence of suicide in persons with cancer. J Clin Oncol. 2008; 26: 4731-4738.
62. Urban D, Rao A, Bressel M, Neiger D, Solomon B, Mileshkin L,. Suicide in lung cancer: Who is at risk? [published online ahead of print May 16, 2013 ]. Chest. doi: 10.1378/;chest.12-2986.
63. Fazel S, Gulati G, Linsell L, Geddes J, Grann M,. Schizophrenia and violence: systematic review and meta-analysis. PLoS Med. 2009; 6: e1000120.
64. Friedman RA,. Violence and mental illness-how strong is the link? N Engl J Med. 2006; 355: 2064-2066.
65. Baggett TP, Hwang SW, O'Connell JJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med. 2013; 173: 189-195.
66. Bauer LK, Baggett TP, Stern TA, O'Connell JJ, Shtasel D,. Caring for homeless persons with serious mental illness in general hospitals. Psychosomatics. 2013; 54: 14-21.
67. O'Connell JJ, Oppenheimer SC, Judge CM, et al. The Boston Health Care for the Homeless Program: a public health framework. Am J Public Health. 2010; 100: 1400-1408.
68. Podymow T, Turnbull J, Coyle D,. Shelter-based palliative care for the homeless terminally ill. Palliat Med. 2006; 20: 81-86.
69. Freeman HP, Chu KC,. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin N Am. 2005; 14: 655-669.
70. Griswold KS, Homish GG, Pastore PA, Leonard KE,. A randomized trial: are care navigators effective in connecting patients to primary care after psychiatric crisis? Community Ment Health J. 2010; 46: 398-402.
71. Kelly E, Fulginiti A, Pahwa R, Tallen L, Duan L, Brekke JS,. A pilot test of a peer navigator intervention for improving the health of individuals with serious mental illness [published online ahead of print July 7, 2013 ]. Community Ment Health J. doi: 10.1007/s10597-013-9616-4.
72. Druss BG, von Esenwein SA, Compton MT, Rask KJ, Zhao L, Parker RM,. A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. Am J Psychiatry. 2010; 167: 151-159.
73. Druss BG, Zhao L, von Esenwein SA, et al. The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness. Schizophr Res. 2010; 118: 264-270.
74. Bowersox NW, Kilbourne AM, Abraham KM, et al. Cause-specific mortality among veterans with serious mental illness lost to follow-up. Gen Hosp Psychiatry. 2012; 34: 651-653.